A strategy for the management of elderly women with primary hyperparathyroidism: A comparison of etidronate therapy with parathyroidectomy

Gerontology

Volumn 48, Issue 2, 2002, Pages 103-108

  Horiuchi, T ^a   Onouchi, T ^a   Inoue, J ^a   Shionoiri, A ^a   Hosoi, T ^a   Orimo, H ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Bone mineral density (BMD); Elderly; Etidronate (EHDP); Parathyroidectomy (PTX); Primary hyperparathyroidism (PHPT)

Indexed keywords

ETIDRONIC ACID;

AGED; ARTICLE; BIOCHEMISTRY; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; LUMBAR SPINE; MEDICAL ASSESSMENT; OSSIFICATION; OSTEOLYSIS; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SPINE FRACTURE; TURNOVER TIME; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; CALCIUM; ETIDRONIC ACID; FEMALE; HORMONES; HUMANS; HYPERPARATHYROIDISM; LONGITUDINAL STUDIES; OSTEOGENESIS; PARATHYROIDECTOMY; TREATMENT OUTCOME;

EID: 0036187622     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048935     Document Type: Article

References (29)

1. Primary hyperparathyroidism and the risk fracture: A population-based study
2. Risk of age-related fractures in patients with primary hyperparathyroidism
3. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
4. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism
5. Long-term effects of dichloromethylene disphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism
6. Clodronate in the medical management of hyperparathyroidism
7. Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: Effect on clinical status
8. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with hyperparathyroidism
9. Decrease of serum calcium concentration and lost influence of calcium on parathyroid hormone release in a patient with primary hyperparathyroidism after treatment with diphosphonates
10. Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism
11. Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone
12. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism
13. Two years of primary hyperparathyroidism with oral alendronate
14. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism
15. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
16. Effects of clodronate on cortical and trabecular bone in ovariectomized rats on a low calcium diet
17. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
18. Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariectomized beagles with calcium restriction
19. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism
20. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: A preliminary report
21. Treatment with oestrogens of primary hyperparathyroidism in postmenopausal women
22. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women
23. Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism
24. Estrogen replacement therapy: A survey of older women's attitudes
25. Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism
26. The effect of parathyroidectomy on the recurrence of nephrolithiasis
27. Changes in renal hemodynamics and tubular function of surgically cured primary hyperparathyroid patients are probably due to chronic hypercalcemic nephropathy
28. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism: A randomized, controlled trial
29. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism